Prescription drug costs

FILE - In this June 14, 2016, file photo, Valeant Pharmaceuticals chairman and CEO Joe Papa speaks to reporters after the company's annual meeting in Laval, Quebec. Valeant Pharmaceuticals now wants to be called Bausch Health Companies, as the Canadian drugmaker continues to distance itself from notoriety gained a few years ago by dramatically hiking the prices of treatments it acquired. Papa said in a statement that the new identity was “a major step forward” in his company’s transformation. (Ryan Remiorz/The Canadian Press via AP, File)
May 08, 2018 - 8:41 am
NEW YORK (AP) — Valeant Pharmaceuticals, which came under heavy scrutiny for acquiring the rights to drugs and then drastically raising their prices, is changing its name. The Canadian company said Tuesday that it will now be called Bausch Health Companies. CEO Joseph Papa said in a prepared...
Read More
FILE - In this Aug. 15, 2017, file photo, Martin Shkreli is interviewed by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. The pharmaceutical-industry entrepreneur vilified for jacking up the price of a lifesaving drug has been placed in a low-security federal prison in New Jersey. Shkreli was moved Tuesday, April 17, 2018, from the Brooklyn Metropolitan Detention Center in New York to the Federal Correctional Institution at Fort Dix. (AP Photo/Richard Drew, File)
April 19, 2018 - 6:47 am
FORT DIX, N.J. (AP) — The pharmaceutical-industry entrepreneur vilified for jacking up the price of a life-saving drug has been placed in a low-security federal prison in New Jersey. Martin Shkreli was moved Tuesday from the Brooklyn Metropolitan Detention Center in New York to the Federal...
Read More
April 19, 2018 - 6:27 am
FORT DIX, N.J. (AP) — The pharmaceutical-industry entrepreneur vilified for jacking up the price of a life-saving drug has been placed in a low-security federal prison in New Jersey. Martin Shkreli was moved Tuesday from the Brooklyn Metropolitan Detention Center in New York to the Federal...
Read More
FILE - In this Feb. 24, 2018, file photo, Department of Health and Human Services Secretary Alex Azar speaks at the National Governor Association 2018 winter meeting in Washington. The Trump administration is taking a pragmatic new track on health care with officials promising consumer-friendly changes and savings in areas from computerized medical records to prescription drugs. Azar has been rolling out the agenda, saying it has the full backing of President Donald Trump.(AP Photo/Jose Luis Magana, File)
March 12, 2018 - 12:10 am
WASHINGTON (AP) — A smartphone app that lets Medicare patients access their claims information. Giving consumers a share of drug company rebates for their prescriptions. Wider access to websites that reliably compare cost and quality of medical tests. The Trump administration is taking a pragmatic...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:40 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:28 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
FILE - In this Aug. 15, 2017 photo, Martin Shkreli is interviewed on the Fox Business Network in New York. Shkreli cried in court Friday, March 9, 2018, as he apologized for defrauding investors while being sentenced by a federal judge. Prosecutors want him sentenced to 15 years in prison, while his defense attorney argued he only deserves 18 months because his investors in two failed hedge funds got their money back. (AP Photo/Richard Drew, File)
March 09, 2018 - 5:16 pm
NEW YORK (AP) — The smirk wiped off his face, a crying Martin Shkreli was sentenced to seven years in prison for securities fraud Friday in a hard fall for the pharmaceutical-industry bad boy vilified for jacking up the price of a lifesaving drug. Shkreli, the boyish-looking, 34-year-old...
Read More
FILE - In this Aug. 15, 2017 photo, Martin Shkreli is interviewed on the Fox Business Network in New York. Shkreli cried in court Friday, March 9, 2018, as he apologized for defrauding investors while being sentenced by a federal judge. Prosecutors want him sentenced to 15 years in prison, while his defense attorney argued he only deserves 18 months because his investors in two failed hedge funds got their money back. (AP Photo/Richard Drew, File)
March 09, 2018 - 4:40 pm
NEW YORK (AP) — The smirk wiped off his face, a crying Martin Shkreli was sentenced to seven years in prison for securities fraud Friday in a hard fall for the pharmaceutical-industry bad boy vilified for jacking up the price of a lifesaving drug. Shkreli, the boyish-looking, 34-year-old...
Read More
FILE - In this Aug. 15, 2017 file photo, former pharmaceutical CEO Martin Shkreli speaks during an interview by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. Shkreli became notorious for raising the price of a life-saving drug by 5,000 percent and trolling critics on the internet with his snarky "Pharma Bro" persona. A federal judge in Brooklyn will have to weigh the conflicting portrayals of Shkreli on Friday, March 9, 2018, at his sentencing on a securities fraud conviction. (AP Photo/Richard Drew, File)
March 09, 2018 - 2:48 pm
NEW YORK (AP) — The Latest on the sentencing of "Pharma Bro" Martin Shkreli (all times local): 2:45 p.m. The attorney for convicted fraudster Martin Shkreli (SHKREL'-ee) says his client is doing "fine" after he was sentenced to seven years in prison. Ben Brafman had asked the judge for a sentence...
Read More
FILE - In this Aug. 15, 2017 file photo, former pharmaceutical CEO Martin Shkreli speaks during an interview by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. Shkreli became notorious for raising the price of a life-saving drug by 5,000 percent and trolling critics on the internet with his snarky "Pharma Bro" persona. A federal judge in Brooklyn will have to weigh the conflicting portrayals of Shkreli on Friday, March 9, 2018, at his sentencing on a securities fraud conviction. (AP Photo/Richard Drew, File)
March 09, 2018 - 2:09 pm
NEW YORK (AP) — Martin Shrkeli, the smirking "Pharma Bro" vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors in two failed hedge funds. The self-promoting pharmaceutical executive notorious for trolling critics online was...
Read More

Pages